As of March 2024 Rigel Pharmaceuticals has a market cap of $0.25 Billion. This makes Rigel Pharmaceuticals the world's 6704th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.25 B | 2.66% |
2023 | $0.25 B | -2.48% |
2022 | $0.25 B | -42.79% |
2021 | $0.45 B | -23.38% |
2020 | $0.59 B | 64.52% |
2019 | $0.35 B | -6.5% |
2018 | $0.38 B | -32.35% |
2017 | $0.56 B | 141.38% |
2016 | $0.23 B | -14.18% |
2015 | $0.27 B | 37.29% |
2014 | $0.19 B | -19.88% |
2013 | $0.24 B | -55.96% |
2012 | $0.56 B | 0.77% |
2011 | $0.56 B | 42.81% |
2010 | $0.39 B | -20.34% |
2009 | $0.49 B | 68.82% |
2008 | $0.29 B | -63.27% |
2007 | $0.79 B | 166.58% |
2006 | $0.29 B | 44.08% |
2005 | $0.20 B | -56.79% |
2004 | $0.48 B | 68.64% |
2003 | $0.28 B | 465.82% |
2002 | $50.31 M | -71.32% |
2001 | $0.17 B |
On Mar 28th, 2024 the market cap of Rigel Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Amgen AMGN | $152.37 B | 58,604.28% | ๐บ๐ธ USA |
AstraZeneca AZN | $210.05 B | 80,826.66% | ๐ฌ๐ง UK |
Sangamo Therapeutics
SGMO | $0.13 B | -47.41% | ๐บ๐ธ USA |
ChemoCentryx CCXI | $3.73 B | 1,340.56% | ๐บ๐ธ USA |